BRPI1006915A2 - composições compreendendo um extrato lipofílico de zingiber officinale e um extrato de cynara scolymus que são úteis para a prevenção e tratamento do refluxo esofágico e da síndrome do cólon irritável. - Google Patents

composições compreendendo um extrato lipofílico de zingiber officinale e um extrato de cynara scolymus que são úteis para a prevenção e tratamento do refluxo esofágico e da síndrome do cólon irritável.

Info

Publication number
BRPI1006915A2
BRPI1006915A2 BRPI1006915A BRPI1006915A BRPI1006915A2 BR PI1006915 A2 BRPI1006915 A2 BR PI1006915A2 BR PI1006915 A BRPI1006915 A BR PI1006915A BR PI1006915 A BRPI1006915 A BR PI1006915A BR PI1006915 A2 BRPI1006915 A2 BR PI1006915A2
Authority
BR
Brazil
Prior art keywords
extract
lipophilic
prevention
compositions
useful
Prior art date
Application number
BRPI1006915A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT000051A external-priority patent/ITMI20090051A1/it
Priority claimed from ITMI2009A001358A external-priority patent/IT1395119B1/it
Application filed by Indena Spa filed Critical Indena Spa
Publication of BRPI1006915A2 publication Critical patent/BRPI1006915A2/pt
Publication of BRPI1006915B1 publication Critical patent/BRPI1006915B1/pt
Publication of BRPI1006915B8 publication Critical patent/BRPI1006915B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1006915A 2009-01-20 2010-01-15 composição compreendendo extrato lipofílico de zingiber officinale e extrato de cynara scolymus, e seu uso BRPI1006915B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI2009A000051 2009-01-20
IT000051A ITMI20090051A1 (it) 2009-01-20 2009-01-20 Composizioni a base di estratto lipofilo di zingiber officinale e di estratto di cynara scolymus per la prevenzione e il trattamento del riflusso esofageo e della sindrome del colon irritabile
ITMI2009A001358A IT1395119B1 (it) 2009-07-29 2009-07-29 Composizioni a base di estratto lipofilo di zingiber officinale e di estratto di cynara scolymus per la prevenzione e il trattamento del riflusso esofageo e della sindrome del colon irritabile
ITMI2009A001358 2009-07-29
PCT/EP2010/000205 WO2010083968A1 (en) 2009-01-20 2010-01-15 Compositions comprising a lipophilic extract of zingiber officinale and an extract of cynara scolymus, which are useful for the prevention and treatment of oesophageal reflux and irritable bowel syndrome

Publications (3)

Publication Number Publication Date
BRPI1006915A2 true BRPI1006915A2 (pt) 2016-02-16
BRPI1006915B1 BRPI1006915B1 (pt) 2021-01-26
BRPI1006915B8 BRPI1006915B8 (pt) 2021-05-25

Family

ID=41820719

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006915A BRPI1006915B8 (pt) 2009-01-20 2010-01-15 composição compreendendo extrato lipofílico de zingiber officinale e extrato de cynara scolymus, e seu uso

Country Status (20)

Country Link
US (1) US10220065B2 (pt)
EP (1) EP2379092B1 (pt)
JP (1) JP5769634B2 (pt)
KR (1) KR101762388B1 (pt)
CN (1) CN102281886A (pt)
AU (1) AU2010206327B2 (pt)
BR (1) BRPI1006915B8 (pt)
CA (1) CA2750030C (pt)
CL (1) CL2011001752A1 (pt)
DK (1) DK2379092T3 (pt)
ES (1) ES2451346T3 (pt)
HR (1) HRP20140197T1 (pt)
IL (1) IL214160A (pt)
MX (1) MX2011007686A (pt)
PL (1) PL2379092T3 (pt)
PT (1) PT2379092E (pt)
RU (1) RU2521250C2 (pt)
SG (1) SG173053A1 (pt)
SI (1) SI2379092T1 (pt)
WO (1) WO2010083968A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101074839B1 (ko) * 2010-11-25 2011-10-19 주식회사 녹십자 금은화 추출물을 포함하는 역류성 식도염 치료 또는 예방용 약학조성물
WO2012105798A2 (ko) * 2011-01-31 2012-08-09 성균관대학교 산학협력단 클로로겐산을 포함하는 위식도 역류 질환의 예방 또는 치료용 조성물
ITMI20111670A1 (it) * 2011-09-16 2013-03-17 Indena Spa Estratti di cynara scolimus per il trattamento di dislipidemie
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
US20150100417A1 (en) * 2013-05-30 2015-04-09 Visa International Service Association Dynamic Checkout Button Apparatuses, Methods and Systems
KR101549746B1 (ko) * 2013-08-22 2015-09-04 충북대학교 산학협력단 생강의 용매분획을 유효성분으로 포함하는 기능성 위장장애 및 위장관 운동장애의 예방 및 치료용 약학적 조성물
US20160189213A1 (en) * 2014-12-31 2016-06-30 Green Dot Corporation Systems and Methods for Targeting Advertising based on Future Purchases
IT202000003092A1 (it) * 2020-02-17 2021-08-17 Neilos S R L Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO990397A0 (en) * 1997-10-22 1997-11-13 R.P. Scherer Holdings Pty Ltd Clear solutions of herbal extracts
DE19859499C2 (de) * 1998-12-22 2002-10-24 Schwabe Willmar Gmbh & Co Stabile Ingwerextraktzubereitung
US20010046523A1 (en) * 2000-02-25 2001-11-29 Thomas Newmark Ginger-based herbal composition for promoting health and methods of using same
TWI290469B (en) * 2000-07-12 2007-12-01 Medical & Pharm Ind Tech & Dev Method for manufacturing product with component capable of efficiently preventing inflammation and platelets agglutination form ginger and medical composition with the efficient component
DE10164893B4 (de) * 2001-08-08 2008-08-28 Divapharma Chur Ag Verfahren zur Herstellung von Artischockenblätterextrakten und so erhaltene Artischockenblätterextrakte
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
WO2008029136A1 (en) * 2006-09-05 2008-03-13 Ultra Biotech Limited Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof
US20080160116A1 (en) 2006-12-07 2008-07-03 Herbalscience Singapore Pte. Ltd Compositions and Methods Comprising Zingiber Species
WO2008074080A1 (en) * 2006-12-20 2008-06-26 David Lubowski Composition and method for treatment of ibs
EP1967199A1 (en) 2007-03-07 2008-09-10 Indena S.P.A. Cynara scolymus extracts and compositions containing them

Also Published As

Publication number Publication date
WO2010083968A1 (en) 2010-07-29
CA2750030A1 (en) 2010-07-29
BRPI1006915B8 (pt) 2021-05-25
IL214160A0 (en) 2011-08-31
CN102281886A (zh) 2011-12-14
SG173053A1 (en) 2011-08-29
RU2011129991A (ru) 2013-02-27
CL2011001752A1 (es) 2012-02-03
JP2012515716A (ja) 2012-07-12
ES2451346T3 (es) 2014-03-26
IL214160A (en) 2016-03-31
PT2379092E (pt) 2014-03-13
EP2379092B1 (en) 2013-12-25
HRP20140197T1 (hr) 2014-04-11
PL2379092T3 (pl) 2014-05-30
RU2521250C2 (ru) 2014-06-27
BRPI1006915B1 (pt) 2021-01-26
KR20110107340A (ko) 2011-09-30
US20120015060A1 (en) 2012-01-19
MX2011007686A (es) 2011-08-12
SI2379092T1 (sl) 2014-03-31
JP5769634B2 (ja) 2015-08-26
US10220065B2 (en) 2019-03-05
EP2379092A1 (en) 2011-10-26
AU2010206327B2 (en) 2015-06-04
CA2750030C (en) 2017-11-07
DK2379092T3 (da) 2014-01-27
KR101762388B1 (ko) 2017-07-28
AU2010206327A1 (en) 2011-08-11

Similar Documents

Publication Publication Date Title
BRPI1006915A2 (pt) composições compreendendo um extrato lipofílico de zingiber officinale e um extrato de cynara scolymus que são úteis para a prevenção e tratamento do refluxo esofágico e da síndrome do cólon irritável.
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0909030A2 (pt) composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
BRPI0822337A2 (pt) Folatos, composições e usos dos mesmos
BRPI1008709A2 (pt) composições e usos das mesmas.
BRPI0923171A2 (pt) Prevenção e tratamento da diarréia causada por rotavírus.
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
BRPI0815841A2 (pt) Métodos e composições para melhoramento de traços preferidos.
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI0807907A2 (pt) co-cristais e composições farmacêuticas compreendendo os mesmos.
AP3031A (en) Avian influenza viruses, compositions, formulations, and methods
CL2013000604A1 (es) Compuestos analogos completamente o parcialmente deuterados de 4-(3-metanosulfonil-fenil)-1-propil-piperidina (pridopidina); composicion farmaceutica que los comprende; y metodo de tratamiento, prevencion o alivio de un trastorno mediado por dopamina.
CL2007003565A1 (es) Compuestos derivados de piperidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion vih.
BRPI1006821A2 (pt) composições para o tratamento da doença de refluxo gastro-esofágico (gerd).
NL2000690A1 (nl) Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine.
BRPI1014583A2 (pt) sulfonamidas heterocíclicos, composições farmacêuticas e usos do mesmo.
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
BRPI1006849A2 (pt) composições compreendendo extratos lipofílicos de zingiber officinale e echinacea angustifolia para a prevenção e o tratamento do refluxo gastroesofágico e da êmese induzida por quimioterapia
DK2467364T3 (da) Nitrogen-holdige forbindelser og farmaceutiske sammensætninger for behandling af atrial flimren.
BRPI0818037A2 (pt) Composições alimentares compreendendo extratos de bálsamo de limão
BRPI0807903A2 (pt) Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno.
BRPI0915077A2 (pt) extrato de rizoma de coptidis e novos usos do mesmo no tratamento da doença respiratória
DK2254408T3 (da) Nematicid-sammensætning, der indeholder salicyladehyd og hvidløgsekstrakt
BRPI1014046A2 (pt) composição, alimento funcional para a saúde, uso de pelo menos um extrato e método para a prevenção ou tratamento da nefrite.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2475 DE 12/06/2018 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/01/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF